Eupraxia Pharmaceuticals Inc. EPRX
6.68 USD +0.08 (+1.21%)
Nov 6, 2026, 10:02 AM EST
6.52 Day range 6.72
5.29 52-week range 9.32
- YTD
- -11.52%
- 1 year
- +19.93%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| -38.43M | -27.00M | -27.85M | -17.62M | |
| -38.61M | -25.74M | -28.97M | -18.99M | |
| -1.03 | -0.76 | -1.17 | -0.96 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| 80.56M | 33.10M | 19.34M | 18.26M | |
| 86.15M | 34.94M | 20.27M | 19.12M | |
| 5.70M | 3.10M | 19.37M | 11.91M | |
| 154.36K | 71.86K | 10.45M | 8.99M | |
| 82.04M | 33.40M | 2.22M | 7.79M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| -28.55M | -29.99M | -20.75M | -14.40M | |
| -588.95K | -75.16K | -73.38K | 9.83M | |
| 76.06M | 45.78M | 21.08M | 10.80M | |
| 46.92M | 15.71M | 256.97K | 6.24M |
